Peking University
Clinical trials sponsored by Peking University, explained in plain language.
-
New Two-Pronged drug aims to shrink tumors before surgery
Disease control OngoingThis study is testing an experimental immunotherapy drug called AK104 for people with locally advanced stomach or colorectal cancer that has a specific genetic feature (MSI-H/dMMR). Participants receive the drug for three cycles before surgery and up to six months after surgery. …
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
New hope for advanced colon cancer patients after standard treatments fail
Disease control OngoingThis study is testing a personalized combination treatment for people with advanced colorectal cancer that has spread to the liver and is no longer responding to standard treatments. The treatment combines a targeted drug (chosen based on a blood test of the tumor's genetics), an…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
Can tablet games keep your mind sharp? study tests brain training for seniors with high blood pressure
Disease control ENROLLING_BY_INVITATIONThis study is testing whether a special brain training program on tablets can help improve thinking skills in older adults who have high blood pressure and are at risk for memory problems. 120 participants aged 60+ will be randomly assigned to either the active brain training pro…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Tailored drug combo tested to better fight common breast cancer
Disease control ENROLLING_BY_INVITATIONThis study aims to see if a more personalized approach improves treatment for early-stage, hormone-positive breast cancer. It will test if adding a targeted drug called a CDK4/6 inhibitor to standard hormone therapy works better for patients identified as having a higher risk of …
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug cocktail tested to shrink tumors before esophageal cancer surgery
Disease control ENROLLING_BY_INVITATIONThis study is testing whether adding two immunotherapy drugs (nimotuzumab and camrelizumab) to standard chemotherapy before surgery helps patients with a type of esophageal cancer. The goal is to see if this combination can completely eliminate the cancer in the removed tissue an…
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
AI on your phone: new app aims to fight depression
Disease control OngoingThis study is testing whether a new mobile app can help treat depression. The app delivers an 8-week digital therapy program based on cognitive behavioral therapy (CBT), guided by artificial intelligence. Researchers are measuring if using the app alongside standard antidepressan…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Smartphones and kindergartens team up to fight childhood obesity
Prevention OngoingThis study is testing a new digital health program designed to prevent obesity in preschool children. It involves kindergartens, parents, and health workers using technology to promote healthy eating and physical activity. Researchers will compare children in the program to those…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC
-
Can we be convinced to trust robot doctors?
Knowledge-focused OngoingThis study aims to understand public opinion about using advanced AI chatbots in healthcare and to test if providing information can change people's minds about accepting them. Researchers from Peking University will survey 3,000 adults online to measure their attitudes before an…
Phase: NA • Sponsor: Peking University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Can AI chatbots teach us about anxiety?
Knowledge-focused OngoingThis study is testing whether AI chatbots can help adults learn more about anxiety and improve their willingness to seek help. Researchers are comparing interactive chatbot conversations to standard educational text. 200 participants will use the assigned tools for one week and a…
Phase: NA • Sponsor: Peking University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC